US Begins Targeted Vaccine Rollout Against Monkeypox
The United States is deploying an enhanced nationwide vaccination strategy to counter the continuing spread of monkeypox.
The United States is deploying an enhanced nationwide vaccination strategy to counter the continuing spread of monkeypox.
On Thursday, New York City became the first U.S. city to start offering the monkeypox vaccine to those at high risk for the disease.
Monkeypox cases continue to climb in the United States, although gradually, federal health officials said Friday.
The number of known U.S. monkeypox cases has increased to 21 in 11 states, federal health officials announced Friday.
Researchers sought to determine the outcomes among pediatric patients with rheumatic disease and COVID-19.
In this retrospective cohort study, researchers assessed the rate of treatment failure among patients with COVID-19 infection who received bamlanivimab vs those who received casirivimab/imdevimab.
Researchers analyzed hospitalized patient data from US medical facilities to assess hospital utilization on the basis of SARS-CoV-2 status.
Investigators compared the clinical course, risk factors, and outcomes of cancer patients with COVID-19 with non-cancer patients with COVID-19.